$WRB

BMO Capital Adjusts Price Target on W.R. Berkley to $69 From $68, Keeps Market Perform Rating

BMO Capital raised its price target for W. R. Berkley from $68 to $69, maintaining a Market Perform rating. The stock closed at $67.54, down 1.00% over five days. The adjustment is based on various composite ratings, including valuation and EPS revisions.

Original reporting
Published Oct 1, 2026, 11:39 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 12:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$WRB
Neutral
medium confidence
Mentioned
$WRB
Relevance
5/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$WRBNeutralMed
01

Why it matters

The modest target increase may prompt short‑term buying interest but is unlikely to drive large price moves.

02

Market read

Small analyst upgrade with limited immediate trading impact.

03

What to watch

Potential macro‑insurance risk factors not addressed in the target change.

Relevance 5/10Novelty 5/10Timing: pre-market

Background

BMO Capital provides rating methodology and composite scores for covered companies.

Company-level read

Ticker impact

$WRBNeutralMedium confidence
Context

BMO Capital raised its price target for W.R. Berkley to $69 from $68, indicating a slightly more bullish outlook.

Expected impact

potential modest upside as the market prices in the higher target

Evidence & confidence

Target lift is small and reflects a slight improvement in valuation expectations.

Market effects

Minor positive signal for the insurance sector.

Limited to U.S. insurers and related investors.

Low global impact.

Counterpoint

Target raise is marginal; price may already reflect the new outlook.

Key entities

  • BMO Capital

    Equity research firm issuing the price target update.

  • W.R. Berkley

    Insurance holding company whose target was adjusted.

Related articles

$TRUPMedAI 8/10

Property & Casualty Insurance Stocks Q2 Results: Benchmarking Trupanion (NASDAQ:TRUP)

Essent Group (ESNT) reported Q2 revenues of $362.7M, up 13.6% YoY, beating estimates. Radian Group (RDN) reported $580.7M in revenues, up 95.7% YoY, but missed EPS estimates. Fidelity National Financial (FNF) reported $4.05B in revenues, up 11.4% YoY, beating estimates. W. R. Berkley (WRB) reported $3.72B in revenues, up 1.2% YoY, missing revenue estimates but beating EPS estimates.

$WRBMed

W. R. Berkley Corporation Reports Second Quarter 2026 Results

BERKLEY W R CORP (WRB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 wrb63020268-kex991.htm EX-99.1 Document NEWS RELEASE W. R. Berkley Corporation 475 Steamboat Road Greenwich, Connecticut 06830 (203) 629-3000 FOR IMMEDIATE RELEASE CONTACT: Karen A. Horvath Vice President - External Financial Communications (203) 629-3000 W. R. Berkley

$KOMed

Coca-Cola (KO) Maintains Buy Rating with $100 Price Target Amid

TD Cowen reaffirmed its 'Buy' rating for Coca-Cola (KO) with a $100 price target, citing a new contract to supply beverages to KFC in the U.S. The deal is expected to boost Coca-Cola's 2027 revenue growth by 10-20 basis points. Coca-Cola's dividend yield is 2.26%, and it has a GF Score of 76/100, indicating strong profitability but lower momentum. Insider selling of $87.9 million in the last three months has been noted.

$NVDAMed

Nvidia's $500B AI Financing Bet Explained [2026]

Nvidia (NASDAQ: NVDA) has secured financing partnerships worth $500B with major financial institutions to fund AI infrastructure. Skeptics question the independence of this capital and whether demand for AI chips is genuine. CEO Jensen Huang has pledged to backstop 25% of these deals, drawing mixed interpretations. The financing arrangements are still in early stages, with no confirmed capital raised yet.